Lifecore Biomedical, Inc.
Price Action
Technical Summary
DOWNTRENDLifecore Biomedical, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 13), showing significant lag compared to the market leaders. Earnings growth of 9% provides fundamental context to the price action. Investors should exercise caution due to high volatility (58% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.10 | -6.55% | BELOW |
| 50 SMA | $5.18 | -7.85% | BELOW |
| 100 SMA | $6.54 | -27.03% | BELOW |
| 150 SMA | $6.76 | -29.46% | BELOW |
| 200 SMA | $6.93 | -31.20% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LFCR in an uptrend right now?
LFCR has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is LFCR overbought or oversold?
LFCR's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is LFCR outperforming the market?
LFCR has a Relative Strength (RS) Rating of 13 out of 99. LFCR is currently lagging the broader market.
Where is LFCR in its 52-week range?
LFCR is trading at $4.77, which is 53% of its 52-week high ($8.98) and 21% above its 52-week low ($3.63).
How volatile is LFCR?
LFCR has a Beta of 1.39 and 52-week volatility of 58%. It's more volatile than the S&P 500 - expect bigger swings.